Browsing tag
Dolutegravir, the current first-line treatment for HIV, may not be as effective as hoped in sub-Saharan Africa, suggests new research published on World AIDS Day….
A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed…
Vaccines have curtailed the spread of several infectious diseases, such as smallpox, polio and measles. However, vaccines against some diseases, including HIV-1, influenza and malaria,…
An immunomodulatory drug called fingolimod, which is approved for the treatment of multiple sclerosis, blocks human immunodeficiency virus (HIV) infection and transmission in human immune…
Technique can track molecules in real time, at room temperature. Viruses are scary. They invade our cells like invisible armies, and each type brings its…
For people living with HIV, any level of alcohol consumption is associated with lower levels of a protein involved in bone formation, raising the risk…
Engineers with the University of Cincinnati have created a tiny portable lab that plugs into your phone, connecting it automatically to a doctor’s office through…
Study: Combination of 2 antibodies taken 30 hours after virus exposure prevents infection in baby monkeys. A single dose of an antibody-based treatment can prevent…
Tesamorelin prevented progression to liver fibrosis in NIH study. Researchers at the National Institutes of Health and their colleagues at Massachusetts General Hospital (MGH) in…
A Yale-led team has discovered yet another molecular trick HIV uses to survive immune system attacks, a finding that may influence efforts to develop an…
Much of the research on HIV has focused on preventing infection but little is understood about how the body keeps the virus in check post-infection….
In a study, a new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV infection. Used in combination with…
Antiretroviral therapies have worked wonders suppressing HIV replication and its progression to AIDS, but their effectiveness is deteriorating due to the constant development of drug…
A new study by the Yale School of Public Health and partner institutions is the first to examine the potential cancer prevention benefits of prolonged…
Soon after an individual’s initial infection with HIV, damage to brain volume and cortical thickness progressively worsens until anti-retroviral treatment is started, a new study…
A team of chemical and biomedical engineers from the Cockrell School of Engineering at The University of Texas at Austin, in collaboration with researchers from…
Research on HIV over the past decade has led to many promising ideas for vaccines to prevent infection by the AIDS virus, but very few…
How do viruses that cause chronic infections, such as HIV or hepatitis c virus, manage to outsmart their hosts’ immune systems? The answer to that…